Stocks and Investing Stocks and Investing
Wed, June 24, 2009
Tue, June 23, 2009
Mon, June 22, 2009

ACL, ATK, SRCL, INT, UL and ANIK Expected To Be Higher Leading Up To Next Earnings Releases


Published on 2009-06-22 12:32:55, Last Modified on 2010-12-22 14:16:19 - WOPRAI
  Print publication without navigation


June 23, 2009 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed before their last 12 quarterly, 6 quarterly and July earnings reports. Alcon (NYSE: ACL), Alliant Techsystems (NYSE: ATK), Stericycle (NASDAQ: SRCL), World Fuel Services (NYSE: INT), Unilever (NYSE: UL) and Anika Therapeutics (NASDAQ: ANIK) are all expected to be higher leading up to their next earnings release. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act before its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go higher leading up to their next earnings release:

Symbol Company # of Reports Quarter Release Date

ACL Alcon Inc July earnings Q2 7/23/2009

ATK Alliant Techsystems August earnings Q1 8/6/2009

SRCL Stericycle, Inc. July earnings Q2 7/23/2009

INT World Fuel Services 12 quarters Q2 8/6/2009

UL Unilever plc (ADR) 12 quarters Q2 8/6/2009

ANIK Anika Therapeutics Inc July earnings Q2 7/21/2009

Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event. because the information is so vital to the market's perception of the vitality of that company.

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

Alcon, Inc. (NYSE: ACL) engages in the development, manufacture, and marketing of pharmaceuticals, surgical equipment and devices, and consumer eye care products to treat primarily diseases and disorders of the eye in the United States and internationally. The company offers various prescription ophthalmic pharmaceutical products for glaucoma treatments; anti-infectives, anti-inflammatories, and combination therapies to treat bacterial, viral, and fungal infections of the eye and to control ocular inflammation; products to treat ocular allergies; combination anti-infective/anti-inflammatory products for ear infections; and generic ophthalmic and otic pharmaceutical products. Its ophthalmic surgical products consist of surgical equipment, single-use, and disposable products for cataract surgery; vitreoretinal surgical products; surgical procedure packs; and refractive products. The company�s consumer eye care products include contact lens care products, such as disinfecting solutions, cleaners, and lens rewetting drops; vision care products, including artificial tears to treat dry eye syndrome and ocular vitamins, as well as dietary supplements, such as Age Related Eye Disease Study Formula, Lutein, and Zeaxanthin formula. Alcon sells its pharmaceutical products to physicians, distributors, wholesalers, hospitals, government agencies, and large retailers; surgical products directly to hospitals and ambulatory surgical centers, and through distributors; and consumer eye care products directly to retailers and optical chains, as well as to distributors for resale directly to smaller retailers and eye care professionals. It has collaboration with River Plate Biotechnology, Inc. to develop hyaluronic acid, a dry eye product. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon, Inc. in December 2001. The company was founded in 1945 and is based in Hunenberg, Switzerland. Alcon, Inc. is a subsidiary of Nestle S.A.

Alliant Techsystems Inc. (NYSE: ATK) supplies aerospace and defense products to the U.S. government agencies, and its prime contractors and subcontractors. The company also supplies ammunition and related accessories to law enforcement agencies and commercial customers. Its ATK Armament Systems segment offers military ammunition and gun systems, such as small-caliber training and tactical ammunition rounds; medium-caliber ammunition, including fighting and light armored vehicles, helicopters, A-10 close-combat support aircraft, and AC-130 gunship aircraft; and chain guns. This segment also provides ammunition, gun care products, targets and traps, rifle scopes and mounts, and binoculars to law enforcement agencies and sport shooting enthusiasts; solid extruded propellant for medium caliber and tank ammunition, artillery charge systems, and air and ground launched rockets; and commercial gun powder for sporting ammunition manufacturers, hunters, and sport shooters. The company�s ATK Mission Systems segment offers missile systems, precision-guided munitions, force protection systems, soldier weapon systems, barrier systems, large-caliber ammunition, tactical and hypersonic propulsion systems, warheads, fuzes, missile defense divert and control systems, electronic warfare and aircraft integration products, structural and engine components, radomes, and apertures. Alliant Techsystems� ATK Space Systems segment manufactures human and cargo launch vehicles, conventional and strategic missiles, missile defense interceptors, and decoy and illuminating flares. This segment also offers solar arrays and solar panel substrates; radio frequency antenna reflectors and antennas; composite bus structures, towers, and subsystems; thermal systems; titanium propellant tanks; and insertion motors, as well as technical services. It operates in the United States, Puerto Rico, and internationally. The company was founded in 1990 and is headquartered in Minneapolis, Minnesota.

Stericycle, Inc. (NASDAQ: SRCL), together with its subsidiaries, provides regulated waste management and return management services in the United States, Canada, Mexico, Argentina, Chile, the United Kingdom, and Ireland. It offers institutional regulated waste management services, Bio Systems sharps management services to reduce the risk of needle sticks, various products and services for infection control, and regulated returns management services for expired or recalled healthcare products. The company serves the large-quantity regulated waste generators, such as hospitals, blood banks, and pharmaceutical manufacturers; and small-quantity generators of regulated waste, which include outpatient clinics, medical and dental offices, long-term and sub-acute care facilities, and retail pharmacies. As of December 31, 2008, Stericycle had a network of 89 processing or combined processing, and collection sites; and 97 additional transfer, collection, or combined transfer and collection sites. The company was founded in 1989 and is based in Lake Forest, Illinois.

World Fuel Services Corporation (NYSE: INT) engages in the marketing and sale of marine, aviation, and land fuel products and related services worldwide. The company�s Marine segment markets fuel and related services to international container and tanker fleets, and time-charter operators, as well as to the United States and foreign governments. Its Aviation segment markets fuel and related services to commercial airlines, second and third-tier airlines, cargo carriers, regional and low cost carriers, corporate fleets, fractional operators, private aircraft, military fleets, and to the United States and foreign governments. Its aviation related services include fuel management and price risk management, as well as arranges and provides ground handling and international trip planning, including flights plans, weather reports, and overflight permits. This segment also offers a private label charge card to customers in the general aviation industry. The company�s Land segment markets fuel and related services to petroleum distributors operating in the land transportation market; and branded and unbranded gasoline and diesel fuel to retail petroleum operators and industrial, commercial, and government customers, as well as operates retail gasoline stations. Its land related services include management services for the procurement of fuel, price risk management, and financing. The company was founded in 1984 and is based in Miami, Florida with additional offices in the United Kingdom, Denmark, Norway, the Netherlands, Germany, Greece, Turkey, the United Arab Emirates, Russia, Taiwan, South Korea, Singapore, Japan, Hong Kong, Costa Rica, Brazil, Chile, Argentina, Mexico, Colombia, Canada, and South Africa.

Unilever PLC (NYSE: UL), together with its subsidiaries, engages in the production and supply of fast moving consumer goods in food, home, and personal care product categories in Western Europe, the Americas, Asia, Africa, and Central and Eastern Europe. The company offers soups, bouillons, sauces, snacks, mayonnaise, salad dressings, olive oil, margarines, spreads, and frozen foods, as well as cooking products, such as liquid margarines under Knorr, Hellmann�s, Becel/Flora, Rama/Blue Band, Calve, WishBone, Amora, Ragu, and Bertolli brands. It also provides ice creams under the international Heart brand, including Cornetto, Magnum, Carte d�Or and Solero, Wall�s, Kibon, Algida, Ola, Ben & Jerry�s, Breyers, Klondike, and Popsicle brands; tea-based beverages under Lipton, Brooke Bond, and PG Tips brands; weight management products under Slim Fast brand; nutritionally enhanced products under Annapurna and AdeS brands; and personal care products, including deodorants, skin care, and hair care products under Dove, Lux, Rexona, Sunsilk, Axe/Lynx, Pond�s, Suave, Clear, Lifebuoy, and Vaseline brands, as well as oral care products under Signal and Close Up brands. In addition, Unilever provides laundry products, such as tablets, powders, liquids, and soap bars under Omo, Surf, Comfort, Radiant, and Skip brands; and household care products, including surface cleaners and bleach under Cif, Domestos, and Sun/Sunlight brands. Additionally, the company offers solutions for professional chefs and caterers. It sells its products through sales force, independent brokers, agents, and distributors to chain, wholesale, co-operative, and independent grocery accounts; food service distributors and institutions; and a network of distribution centers, satellite warehouses, company-operated and public storage facilities, and depots. The company, formerly known as Lever Brothers Limited, was founded in 1885 and is based in London, the United Kingdom. Unilever PLC is a subsidiary of The Unilever Group.

Anika Therapeutics, Inc. (NASDAQ: ANIK) develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid (HA), a naturally occurring biocompatible polymer found in the body. The company offers ORTHOVISC, an HA product used in the treatment of some forms of osteoarthritis in humans; and AMVISC, AMVISC Plus, STAARVISC-II, and ShellGel that are injectable ophthalmic viscoelastic HA products used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation. It also provides HYVISC, an HA product used in the treatment of equine osteoarthritis; INCERT, an HA based anti-adhesive for surgical applications; and ORTHOVISC mini, a treatment for osteoarthritis targeting small joints. In addition, the company offers MONOVISC, a single-injection osteoarthritis product for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine osteoarthritis; and ELEVESS, which is designed as a family of aesthetic dermatology products for facial wrinkles, scar remediation, and lip augmentation. Further, it involves in the research and development of joint health related products, such as a single-injection treatment product that uses a non-animal source HA. Anika Therapeutics, Inc. offers its products in the United States, as well as in Canada, Europe, Turkey, the Middle East, and Asia through representatives, agents, and distributors. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

One example from the SqueezeTrigger database is approximately 2.5 billion short sale transactions going back to January 1, 2005, and SqueezeTrigger calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com

Go to www.SqueezeTrigger.com to find out the exact price that the entire Total Short Interest will start covering!

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month�s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

Contributing Sources